AABB is committed to protecting, supporting, and advancing research that drives innovation and progress in transfusion medicine and biotherapies. The Association champions robust, sustained federal funding for research, which is critical to shaping evidence-based policies, enhancing blood donor safety, and improving patient outcomes. AABB fosters collaboration among public and private stakeholders to address current and emerging challenges in the field.